Evidence map›Paper›PMID 16061723›Full record

ReviewThe Journal of experimental medicine2005

Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.

Annett M Jacobi, Betty Diamond

Abstract readCommentReview
In one paragraph

Review in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Immune cell subset differentiation and tissue inflammation.Journal of hematology & oncology · 2018
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Local renal autoantibody production in lupus nephritis.Journal of the American Society of Nephrology : JASN · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Annett M JacobiDepartment of Rheumatology and Clinical Immunology, Charite University Hospital, 10117 Berlin, Germany.
Betty Diamond

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autoimmune disease systemic lupus erythematosus (SLE) is caused by a failure of B cell tolerance. Recent studies in mouse models of SLE have identified several distinct tolerance checkpoints that must each function appropriately to protect against disease. However, studies of B cell repertoire selection in humans are essential to understand which checkpoints are defective in human autoimmune diseases.

Indexed as

AutoimmunityAnimalsB-LymphocytesHumansImmune ToleranceLupus Erythematosus, SystemicMice

Identifiers

PMID16061723
PMCPMC2213089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.